SEC Form 4 · accession 0001646649-26-000029
Natera, Inc. · NTRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan Sheena
Director · Other
Period of report
Aug 7, 2026
Accepted (ET)
Aug 7, 2026 · 9:35 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001604821
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 7, 2026 | S | 100 | $308.40 | D | 245,514 | D | |
| Common StockF1,F2 | Aug 7, 2026 | S | 400 | $310.225 | D | 245,114 | D | |
| Common StockF1,F3 | Aug 7, 2026 | S | 400 | $311.8788 | D | 244,714 | D | |
| Common StockF1,F4 | Aug 7, 2026 | S | 900 | $313.0672 | D | 243,814 | D | |
| Common StockF1,F5 | Aug 7, 2026 | S | 850 | $314.2517 | D | 242,964 | D | |
| Common StockF1,F6 | Aug 7, 2026 | S | 600 | $315.3175 | D | 242,364 | D | |
| Common StockF1,F7 | Aug 7, 2026 | S | 5,111 | $316.6118 | D | 237,253 | D | |
| Common StockF1,F8 | Aug 7, 2026 | S | 200 | $317.965 | D | 237,053 | D | |
| Common StockF1 | Aug 7, 2026 | S | 100 | $318.63 | D | 236,953 | D | |
| Common StockF1 | Aug 7, 2026 | S | 489 | $320.90 | D | 236,464 | D | |
| Common StockF9 | holding | — | — | — | 18,032 | I | By Caraluna 1 Trust | |
| Common StockF9 | holding | — | — | — | 18,032 | I | By Caraluna 2 Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
- F2The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $309.9250 to $310.5250 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $311.5050 to $312.5000 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $312.5950 to $313.3150 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $313.9500 to $314.7150 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $315.04 to $315.67 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F7The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.10 to $316.78 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F8The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.62 to $318.31 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F9Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.